Takeover watchdog appoints investigator amid complaints at Ascendis Health

The Takeover Regulation Panel (TRP) said on Friday it has appointed an investigator for Ascendis Health after a litany of complaints at a firm that is eyeing delisting from the JSE this year. These include complaints about shareholders acting in party with a buyout consortium, as well as other "other instances of non-compliance."

Ascendis, meanwhile, says the move follows engagement with the regulator in a bid to bring finality for a transaction delayed by the "continual drip-feeding" of complaints.